Month: August 2011

Stock Analysts

Harsco Addresses Environmental Worry (HSC)

August 16, 2011 0

In an endeavor to advance the capture and reuse of steel mill flue gases as an environment ally significant source of reliable energy, Harsco Corporation ( HSC ) recently formed a strategic alliance with LanzaTech, a clean energy technology company. The financial terms of the transaction were not disclosed. […]

Stock Analysts

Industrial Production Up More than Expected (BTU) (CAT) (FCX) (JOYG) (SPX)

August 16, 2011 0

Total Industrial Production rose 0.9% in July, which was well above the expected 0.4% increase. The report is stronger than that would indicate, since both May and June were revised up — May from down 0.1% to up 0.2% and June from a 0.2% increase to up 0.4%. That is a solid performance, and should help put fears that we are on the cusp of a new recession (rather than just continued sluggish growth) to rest. […]

Mergers & Acquisitions

Williams Affirms Proposal to Acquire Southern Union for $44.00 per Share in Cash

August 16, 2011 0

Williams Affirms Proposal to Acquire Southern Union for $44.00 per Share in Cash — Recent Market Volatility Underscores Benefits of Williams’ All-Cash Proposal — Williams’ Offer Delivers Southern Union Shareholders Value Certainty vs. Energy Transfer Agreement, Which Includes Volatile and Illiquid Partnership Units — Due Diligence Is Complete — Williams Reiterates Commitment to Take All Actions Necessary to Obtain Regulatory Approval — Williams’ Transaction Not Conditioned Upon Financing — Williams Sees Southern Union Assets as Strategic Fit; Well-Aligned With High-Dividend, High-Growth Direction PR Newswire TULSA, Okla., Aug. 16, 2011 TULSA, Okla […]

FDA Approval

Abbott Receives FDA Approval for Two Three-Month Strengths of Lupron Depot-PED (leuprolide acetate for depot suspension) for the Treatment of Central Precocious Puberty (CPP)

August 16, 2011 0

Abbott Receives FDA Approval for Two Three-Month Strengths of Lupron Depot-PED (leuprolide acetate for depot suspension) for the Treatment of Central Precocious Puberty (CPP) Two new strengths in a three-month formulation expand Lupron Depot-PED dosing options for children with CPP PR Newswire ABBOTT PARK, Ill., Aug. 16, 2011 ABBOTT PARK, Ill., Aug. 16, 2011 /PRNewswire/ — Abbott (NYSE: ABT) announced today that the U.S. […]

Stock Analysts

Gilead’s Quad Meets Study Goal (BMY) (GILD) (JNJ)

August 16, 2011 0

Gilead Sciences Inc. ’s (GILD ) HIV franchise received yet another boost with a late stage clinical trial of its pipeline HIV combination pill Quad meeting the primary endpoint. The much anticipated Quad pill is a combination of Gilead’s pipeline candidate elvitegravir, cobicistat (GS 9350), and Truvada. […]

Stock Analysts

Pfizer Scores in Viagra Litigation (PFE) (TEVA)

August 16, 2011 0

Pfizer Inc. ( PFE ) recently received a favorable ruling in its patent infringement case against Teva Pharmaceuticals ( TEVA ). Teva had filed an abbreviated new drug application with the US Food and Drug Administration (FDA) seeking approval for its generic version of Viagra. […]